Cite
[On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma].
MLA
Gholamrezanezhad, Ali, et al. “[On-Levothyroxine Measurement of Thyroglobulin Is Not a Reliable Test for the Follow-up of Patients at High Risk for Remnant/Recurrent Differentiated Thyroid Carcinoma].” Endokrynologia Polska, vol. 58, no. 2, Mar. 2007, pp. 100–04. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17578824&authtype=sso&custid=ns315887.
APA
Gholamrezanezhad, A., Saghari, M., Mirpour, S., Beiki, D., Tarbiat, A., Javan, S., & Abdollahzadeh, J. (2007). [On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma]. Endokrynologia Polska, 58(2), 100–104.
Chicago
Gholamrezanezhad, Ali, Mohsen Saghari, Sahar Mirpour, Davood Beiki, Ali Tarbiat, Shabnam Javan, and Javaher Abdollahzadeh. 2007. “[On-Levothyroxine Measurement of Thyroglobulin Is Not a Reliable Test for the Follow-up of Patients at High Risk for Remnant/Recurrent Differentiated Thyroid Carcinoma].” Endokrynologia Polska 58 (2): 100–104. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17578824&authtype=sso&custid=ns315887.